Status: Recruiting
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of Care (SOC) has failed or has proven intolerable.
Participants needed: 48
Trial details
Phase: Phase 1Age: 21+Biological sex: AllType: InterventionalSponsor: MBQ PharmaUpdated: Dec 12, 2024Locations: 4
Eligibility criteria
The investigator will evaluate these and other criteria to determine whether a p... [+4]
The investigator will evaluate these and other criteria to determine whether a p... [+5]